Healthcare

Majority in India prefer diagnostic centres over hospitals: report

Individuals choose these facilities for preventive health checkups
1 day ago

Global hospital services to be valued at $24.17t by 2034

By hospital, the private hospital segment is anticipated to grow at the fastest rate.
2 days ago

Global venipuncture procedure market to hit $1.5b by 2030

Its growth is attributed to the increasing demand for diagnostic testing.
4 days ago

Remote surgery technology platforms market to hit $10.52b by 2034

Its growth is attributed to the rising demand for minimally invasive surgeries.

APAC eyes fastest growth in global cardiovascular information system market

Thanks to rapid urbanisation and increased healthcare spending.

Global cancer immunotherapy market to be valued at $247.2b by 2029

Developments in genomics, AI, and biotechnology are driving market growth.

APAC to see fastest growth in global care management solutions market

China, India, and Japan are investing heavily in healthcare IT infrastructure.

7MM sarcopenia market to see 8.1% CAGR growth until 2034

There are currently no approved drugs to treat the condition.

India’s dialysis machines market eyes 2% CAGR growth until 2036

It accounted for around 3% of the Asia-Pacific market in 2024.

APAC eyes fastest growth in global body composition analysers market

The global market is projected to hit $935.8m by 2032.

APAC healthcare workers voice concerns over AI, data gaps

Over seven in ten are uncertain about legal liability in AI usage.

7MM atopic dermatitis market to be valued at $22.4b by 2033

The estimated drug-treated population may grow to over 25,100,000 people.

What factors drive the 7MM Angelman syndrome market?

The rare neurogenetic disorder affects around 500,000 people worldwide.

What lies ahead of the global healthcare transportation services market?

Digitalisation is shifting the sector to an integrated service ecosystem.

Medical cannabis market to hit $87.41b by 2030

The global advancement of its legislation is a key growth driver.

China’s biopharma sector strikes $30b in oncology licensing deals

Antibody-drug conjugates dominated licensing activity in 2024.